Catalyst Wire Dossier Catalyst Wire Dossier

REGN9933

· Regeneron Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for REGN9933, covering 2025-07-16 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Learn How Well REGN9933 and REGN7508 Work for Preventing Blood Clots, and How Safe They Are, in Adults Who Have a Peripherally Inserted Central Catheter (PICC) [Phase 2]

See pricing